Mikhail Blagosklonny: Harnessing the Potential of Rapamycin

Mankind has been fascinated with being immortal for years. Lore and myth surrounding immortal beings are prevalent in ancient civilizations, and mankind has been researching how to attain eternal life. Recently, a group of scientists from the United States have proposed a theory on how immortality can be achieved. According to the theory, the key to immortality is understanding that aging is actually a disease that can be cured, and the substance to be used is rapamycin, which is currently being used against cancer and all of its effects. The leader of the group researching on rapamycin is Dr. Mikhail Blagosklonny, who is an oncologist and a professor at the Roswell Park Cancer Institute. Dr. Mikhail Blagosklonny have presented his research to the scientific community a few years ago, but they ridiculed him and told him that immortality is based on fantasy. The experience he had facing the scientific community inspired him to do further research, to prove the scientists who thought about his idea as a ridiculous fantasy wrong.

Dr. Mikhail Blagosklonny graduated from the First Pavlov State Medical University of St. Petersburg, and he received several degrees during his study. Right after graduation, he moved to the Roswell Park Cancer Institute to become a professor of oncology, and his fascination with immortality stemmed from his discovery about the potential use of rapamycin. Being a professor who is teaching about cancer, its causes, and the possible cure, he is exposed to different chemicals and substances which are being used today against the disease. One day, upon researching about cancer, he discovered that rapamycin can actually regenerate cells which have been degenerated. This curiosity managed to spawn several other studies, confirming his theory about the substance. He immediately formed a team of scientists who will be studying the substance and their goal is to find out how rapamycin can be made into a wonder drug.

Based on the research of Dr. Mikhail Blagosklonny, rapamycin has two centric models, called the TOR and the MTOR model. These centric models are responsible for the regeneration of the cells inside the body. They wanted to find out how rapamycin with TOR and MTOR model can be obtained, and through studying thoroughly, they found out that these centric models can be obtained from genes, which makes it passable to off springs; it can also be obtained through cellular senescence, which means that newer cells that has been regenerated can have the centric models; and finally, is from diseases. Their study also found out that rapamycin can actually strengthen one’s immune system, and the cells which have been deteriorated can return back to its juvenile state.The research of Dr. Mikhail Blagosklonny made headlines, and soon, other pharmaceutical companies have started their venture on discovering the key to immortality. They are basing their production on the research of Dr. Mikhail Blagosklonny, and one of these companies who are serious about being the first one to introduce the key to immortality is Novartis. Dr. Mikhail Blagosklonny must race against time to be given the proper credit.

Comments are closed.